Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

Cited In for PubMed (Select 11772973)

1.

The haemodynamic effects of the perioperative terlipressin infusion in living donor liver transplantation: A randomised controlled study.

Ibrahim N, Hasanin A, Allah SA, Sayed E, Afifi M, Yassen K, Saber W, Khalil M.

Indian J Anaesth. 2015 Mar;59(3):156-64. doi: 10.4103/0019-5049.153037.

2.

Paracentesis-induced circulatory dysfunction: a primer for the interventional radiologist.

Lindsay AJ, Burton J, Ray CE Jr.

Semin Intervent Radiol. 2014 Sep;31(3):276-8. doi: 10.1055/s-0034-1382799. Review.

PMID:
25177092
3.

Beta-blockers in liver cirrhosis.

Giannelli V, Lattanzi B, Thalheimer U, Merli M.

Ann Gastroenterol. 2014;27(1):20-26. Review.

4.

The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis.

Bari K, Miñano C, Shea M, Inayat IB, Hashem HJ, Gilles H, Heuman D, Garcia-Tsao G.

Clin Gastroenterol Hepatol. 2012 Oct;10(10):1169-75. doi: 10.1016/j.cgh.2012.06.027. Epub 2012 Jul 16.

5.

Kidneys in chronic liver diseases.

Hartleb M, Gutkowski K.

World J Gastroenterol. 2012 Jun 28;18(24):3035-49. doi: 10.3748/wjg.v18.i24.3035. Review.

6.

Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.

Nasr G, Hassan A, Ahmed S, Serwah A.

J Cardiovasc Dis Res. 2010 Jul;1(3):136-44. doi: 10.4103/0975-3583.70914.

7.

Pathogenetic background for treatment of ascites and hepatorenal syndrome.

Møller S, Henriksen JH, Bendtsen F.

Hepatol Int. 2008 Dec;2(4):416-28. doi: 10.1007/s12072-008-9100-3. Epub 2008 Sep 20.

8.

Evaluation and management of patients with refractory ascites.

Senousy BE, Draganov PV.

World J Gastroenterol. 2009 Jan 7;15(1):67-80. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk